Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2016 | Pages:
1153 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Head And Neck Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape. Head and Neck Cancer is a cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx). The common symptoms of cancer of the head and neck include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. The disease may be controlled by chemotherapy and radiation therapy. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Head And Neck Cancer - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Head And Neck Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 17, 73, 86, 6, 76, 18 and 2 respectively for Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 9, 6, 16 and 3 molecules, respectively for Head And Neck Cancer. Head And Neck Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data. Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Head And Neck Cancer (Oncology). - The pipeline guide reviews pipeline therapeutics for Head And Neck Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Head And Neck Cancer (Oncology) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Head And Neck Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Head And Neck Cancer (Oncology) Reasons To Buy - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Head And Neck Cancer (Oncology). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Head And Neck Cancer (Oncology) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2 Introduction 9 Head And Neck Cancer Overview 10 Therapeutics Development 11 Head And Neck Cancer - Therapeutics under Development by Companies 13 Head And Neck Cancer - Therapeutics under Investigation by Universities/Institutes 27 Head And Neck Cancer - Pipeline Products Glance 29 Head And Neck Cancer - Products under Development by Companies 33 Head And Neck Cancer - Products under Investigation by Universities/Institutes 54 Head And Neck Cancer - Companies Involved in Therapeutics Development 57 Head And Neck Cancer - Therapeutics Assessment 225 Drug Profiles 260 Head And Neck Cancer - Dormant Projects 1081 Head And Neck Cancer - Discontinued Products 1097 Head And Neck Cancer - Product Development Milestones 1100 Appendix 1119
List of Tables
Number of Products under Development for Head And Neck Cancer, H2 2016 44 Number of Products under Development for Head And Neck Cancer - Comparative Analysis, H2 2016 45 Number of Products under Development by Companies, H2 2016 46 Number of Products under Development by Companies, H2 2016 (Contd..1) 47 Number of Products under Development by Companies, H2 2016 (Contd..2) 48 Number of Products under Development by Companies, H2 2016 (Contd..3) 49 Number of Products under Development by Companies, H2 2016 (Contd..4) 50 Number of Products under Development by Companies, H2 2016 (Contd..5) 51 Number of Products under Development by Companies, H2 2016 (Contd..6) 52 Number of Products under Development by Companies, H2 2016 (Contd..7) 53 Number of Products under Development by Companies, H2 2016 (Contd..8) 54 Number of Products under Development by Companies, H2 2016 (Contd..9) 55 Number of Products under Development by Companies, H2 2016 (Contd..10) 56 Number of Products under Development by Companies, H2 2016 (Contd..11) 57 Number of Products under Development by Companies, H2 2016 (Contd..12) 58 Number of Products under Development by Companies, H2 2016 (Contd..13) 59 Number of Products under Investigation by Universities/Institutes, H2 2016 60 Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 61 Comparative Analysis by Late Stage Development, H2 2016 62 Comparative Analysis by Clinical Stage Development, H2 2016 63 Comparative Analysis by Early Stage Development, H2 2016 64 Comparative Analysis by Unknown Stage Development, H2 2016 65 Products under Development by Companies, H2 2016 66 Products under Development by Companies, H2 2016 (Contd..1) 67 Products under Development by Companies, H2 2016 (Contd..2) 68 Products under Development by Companies, H2 2016 (Contd..3) 69 Products under Development by Companies, H2 2016 (Contd..4) 70 Products under Development by Companies, H2 2016 (Contd..5) 71 Products under Development by Companies, H2 2016 (Contd..6) 72 Products under Development by Companies, H2 2016 (Contd..7) 73 Products under Development by Companies, H2 2016 (Contd..8) 74 Products under Development by Companies, H2 2016 (Contd..9) 75 Products under Development by Companies, H2 2016 (Contd..10) 76 Products under Development by Companies, H2 2016 (Contd..11) 77 Products under Development by Companies, H2 2016 (Contd..12) 78 Products under Development by Companies, H2 2016 (Contd..13) 79 Products under Development by Companies, H2 2016 (Contd..14) 80 Products under Development by Companies, H2 2016 (Contd..15) 81 Products under Development by Companies, H2 2016 (Contd..16) 82 Products under Development by Companies, H2 2016 (Contd..17) 83 Products under Development by Companies, H2 2016 (Contd..18) 84 Products under Development by Companies, H2 2016 (Contd..19) 85 Products under Development by Companies, H2 2016 (Contd..20) 86 Products under Investigation by Universities/Institutes, H2 2016 87 Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 88 Products under Investigation by Universities/Institutes, H2 2016 (Contd..2) 89 Head And Neck Cancer - Pipeline by 3SBio Inc., H2 2016 90 Head And Neck Cancer - Pipeline by 4SC AG, H2 2016 91 Head And Neck Cancer - Pipeline by AB Science SA, H2 2016 92 Head And Neck Cancer - Pipeline by AbbVie Inc, H2 2016 93 Head And Neck Cancer - Pipeline by Accelerated Pharma, Inc., H2 2016 94 Head And Neck Cancer - Pipeline by Acceleron Pharma, Inc., H2 2016 95 Head And Neck Cancer - Pipeline by Adaptimmune Therapeutics Plc, H2 2016 96 Head And Neck Cancer - Pipeline by Aduro BioTech, Inc., H2 2016 97 Head And Neck Cancer - Pipeline by Advaxis, Inc., H2 2016 98 Head And Neck Cancer - Pipeline by Advenchen Laboratories, LLC, H2 2016 99 Head And Neck Cancer - Pipeline by Affimed GmbH , H2 2016 100 Head And Neck Cancer - Pipeline by Alchemia Limited, H2 2016 101 Head And Neck Cancer - Pipeline by Altor BioScience Corporation, H2 2016 102 Head And Neck Cancer - Pipeline by Ambrx, Inc., H2 2016 103 Head And Neck Cancer - Pipeline by Amgen Inc., H2 2016 104 Head And Neck Cancer - Pipeline by arGEN-X BV, H2 2016 105 Head And Neck Cancer - Pipeline by ArQule, Inc., H2 2016 106 Head And Neck Cancer - Pipeline by Aspyrian Therapeutics, Inc., H2 2016 107 Head And Neck Cancer - Pipeline by Astellas Pharma Inc., H2 2016 108 Head And Neck Cancer - Pipeline by AstraZeneca Plc, H2 2016 109 Head And Neck Cancer - Pipeline by Atara Biotherapeutics, Inc., H2 2016 110 Head And Neck Cancer - Pipeline by ATLAB Pharma SAS, H2 2016 111 Head And Neck Cancer - Pipeline by Aura Biosciences, Inc., H2 2016 112 Head And Neck Cancer - Pipeline by AVEO Pharmaceuticals, Inc., H2 2016 113 Head And Neck Cancer - Pipeline by Bayer AG, H2 2016 114 Head And Neck Cancer - Pipeline by Betta Pharmaceuticals Co. Ltd., H2 2016 115 Head And Neck Cancer - Pipeline by Bexion Pharmaceuticals, LLC, H2 2016 116 Head And Neck Cancer - Pipeline by Bio-Path Holdings, Inc., H2 2016 117 Head And Neck Cancer - Pipeline by BioDiem Ltd, H2 2016 118 Head And Neck Cancer - Pipeline by Biomics Biotechnologies Co., Ltd., H2 2016 119 Head And Neck Cancer - Pipeline by Bionovis SA, H2 2016 120 Head And Neck Cancer - Pipeline by BioNTech AG, H2 2016 121 Head And Neck Cancer - Pipeline by Biotest AG, H2 2016 122 Head And Neck Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2016 123 Head And Neck Cancer - Pipeline by Boston Biomedical, Inc., H2 2016 124 Head And Neck Cancer - Pipeline by Bristol-Myers Squibb Company, H2 2016 125 Head And Neck Cancer - Pipeline by Calithera Biosciences, Inc., H2 2016 126 Head And Neck Cancer - Pipeline by CEL-SCI Corporation, H2 2016 127 Head And Neck Cancer - Pipeline by Celgene Corporation, H2 2016 128 Head And Neck Cancer - Pipeline by Cell Medica Limited, H2 2016 129 Head And Neck Cancer - Pipeline by Cellceutix Corporation, H2 2016 130 Head And Neck Cancer - Pipeline by Celldex Therapeutics, Inc., H2 2016 131 Head And Neck Cancer - Pipeline by Celprogen, Inc., H2 2016 132 Head And Neck Cancer - Pipeline by Centrose LLC, H2 2016 133 Head And Neck Cancer - Pipeline by Corvus Pharmaceuticals, Inc., H2 2016 134 Head And Neck Cancer - Pipeline by Cristal Therapeutics B.V., H2 2016 135 Head And Neck Cancer - Pipeline by Critical Outcome Technologies Inc., H2 2016 136 Head And Neck Cancer - Pipeline by CTI BioPharma Corp., H2 2016 137 Head And Neck Cancer - Pipeline by Daiichi Sankyo Company, Limited, H2 2016 138 Head And Neck Cancer - Pipeline by DNJ Pharma, Inc., H2 2016 139 Head And Neck Cancer - Pipeline by Eisai Co., Ltd., H2 2016 140 Head And Neck Cancer - Pipeline by Eleven Biotherapeutics Inc., H2 2016 141 Head And Neck Cancer - Pipeline by Eli Lilly and Company, H2 2016 142 Head And Neck Cancer - Pipeline by EntreChem, S.L., H2 2016 143 Head And Neck Cancer - Pipeline by Etubics Corporation, H2 2016 144 Head And Neck Cancer - Pipeline by Eureka Therapeutics, Inc., H2 2016 145 Head And Neck Cancer - Pipeline by F. Hoffmann-La Roche Ltd., H2 2016 146 Head And Neck Cancer - Pipeline by Five Prime Therapeutics, Inc., H2 2016 147 Head And Neck Cancer - Pipeline by G&E Herbal Biotechnology Co., Ltd., H2 2016 148 Head And Neck Cancer - Pipeline by Genelux Corporation, H2 2016 149 Head And Neck Cancer - Pipeline by GeneSegues Inc, H2 2016 150 Head And Neck Cancer - Pipeline by Genexine, Inc., H2 2016 151 Head And Neck Cancer - Pipeline by Genmab A/S, H2 2016 152 Head And Neck Cancer - Pipeline by Genticel S.A., H2 2016 153 Head And Neck Cancer - Pipeline by GlaxoSmithKline Plc, H2 2016 154 Head And Neck Cancer - Pipeline by Gliknik, Inc., H2 2016 155 Head And Neck Cancer - Pipeline by Glycotope GmbH, H2 2016 156 Head And Neck Cancer - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2016 157 Head And Neck Cancer - Pipeline by Hookipa Biotech AG, H2 2016 158 Head And Neck Cancer - Pipeline by Horizon Pharma Plc, H2 2016 159 Head And Neck Cancer - Pipeline by Hutchison MediPharma Limited, H2 2016 160 Head And Neck Cancer - Pipeline by Ignyta, Inc., H2 2016 161 Head And Neck Cancer - Pipeline by Immunomedics, Inc., H2 2016 162 Head And Neck Cancer - Pipeline by Immunovaccine, Inc., H2 2016 163 Head And Neck Cancer - Pipeline by Immunovative Therapies, Ltd., H2 2016 164 Head And Neck Cancer - Pipeline by Incuron, LLC, H2 2016 165 Head And Neck Cancer - Pipeline by Incyte Corporation, H2 2016 166 Head And Neck Cancer - Pipeline by Infinity Pharmaceuticals, Inc., H2 2016 167 Head And Neck Cancer - Pipeline by Innate Pharma S.A., H2 2016 168 Head And Neck Cancer - Pipeline by Inovio Pharmaceuticals, Inc., H2 2016 169 Head And Neck Cancer - Pipeline by InteRNA Technologies B.V., H2 2016 170 Head And Neck Cancer - Pipeline by IRX Therapeutics, Inc., H2 2016 171 Head And Neck Cancer - Pipeline by ISA Pharmaceuticals B.V., H2 2016 172 Head And Neck Cancer - Pipeline by Jiangsu Kanion Pharmaceutical Co., Ltd., H2 2016 173 Head And Neck Cancer - Pipeline by Johnson & Johnson, H2 2016 174 Head And Neck Cancer - Pipeline by Kite Pharma Inc, H2 2016 175 Head And Neck Cancer - Pipeline by Kolltan Pharmaceuticals, Inc., H2 2016 176 Head And Neck Cancer - Pipeline by Kura Oncology, Inc., H2 2016 177 Head And Neck Cancer - Pipeline by Laboratoires Pierre Fabre SA, H2 2016 178 Head And Neck Cancer - Pipeline by Lakewood-Amedex Inc, H2 2016 179 Head And Neck Cancer - Pipeline by Loxo Oncology, Inc., H2 2016 180 Head And Neck Cancer - Pipeline by Lytix Biopharma AS, H2 2016 181 Head And Neck Cancer - Pipeline by Mabion SA, H2 2016 182 Head And Neck Cancer - Pipeline by Mabtech Limited, H2 2016 183 Head And Neck Cancer - Pipeline by MacroGenics, Inc., H2 2016 184 Head And Neck Cancer - Pipeline by Marsala Biotech Inc., H2 2016 185 Head And Neck Cancer - Pipeline by Mateon Therapeutics Inc, H2 2016 186 Head And Neck Cancer - Pipeline by MaxiVAX SA, H2 2016 187 Head And Neck Cancer - Pipeline by Meabco A/S, H2 2016 188 Head And Neck Cancer - Pipeline by MedImmune, LLC, H2 2016 189 Head And Neck Cancer - Pipeline by Merck & Co., Inc., H2 2016 190 Head And Neck Cancer - Pipeline by Merck KGaA, H2 2016 191 Head And Neck Cancer - Pipeline by Merrimack Pharmaceuticals, Inc., H2 2016 192 Head And Neck Cancer - Pipeline by Millennium Pharmaceuticals Inc, H2 2016 193 Head And Neck Cancer - Pipeline by Mirati Therapeutics Inc., H2 2016 194 Head And Neck Cancer - Pipeline by Molecular Partners AG, H2 2016 195 Head And Neck Cancer - Pipeline by Moleculin Biotech Inc, H2 2016 196 Head And Neck Cancer - Pipeline by Molplex Ltd., H2 2016 197 Head And Neck Cancer - Pipeline by NanoCarrier Co., Ltd., H2 2016 198 Head And Neck Cancer - Pipeline by Natco Pharma Limited, H2 2016 199 Head And Neck Cancer - Pipeline by Neonc Technologies Inc, H2 2016 200 Head And Neck Cancer - Pipeline by Northwest Biotherapeutics, Inc., H2 2016 201 Head And Neck Cancer - Pipeline by Novartis AG, H2 2016 202 Head And Neck Cancer - Pipeline by Omnitura Therapeutics Inc., H2 2016 203 Head And Neck Cancer - Pipeline by Oncobiologics, Inc., H2 2016 204 Head And Neck Cancer - Pipeline by Oncolys BioPharma Inc, H2 2016 205 Head And Neck Cancer - Pipeline by Oncolytics Biotech Inc., H2 2016 206 Head And Neck Cancer - Pipeline by Onconova Therapeutics, Inc., H2 2016 207 Head And Neck Cancer - Pipeline by OncoSec Medical Incorporated, H2 2016 208 Head And Neck Cancer - Pipeline by Ono Pharmaceutical Co., Ltd., H2 2016 209 Head And Neck Cancer - Pipeline by Oryx GmbH & Co. KG, H2 2016 210 Head And Neck Cancer - Pipeline by Panacea Biotec Limited, H2 2016 211 Head And Neck Cancer - Pipeline by PCI Biotech Holding ASA, H2 2016 212 Head And Neck Cancer - Pipeline by PDS Biotechnology Corporation, H2 2016 213 Head And Neck Cancer - Pipeline by Pfizer Inc., H2 2016 214 Head And Neck Cancer - Pipeline by Pharma Mar, S.A., H2 2016 215 Head And Neck Cancer - Pipeline by Pique Therapeutics, H2 2016 216 Head And Neck Cancer - Pipeline by PlantForm Corporation, H2 2016 217 Head And Neck Cancer - Pipeline by Plexxikon Inc., H2 2016 218 Head And Neck Cancer - Pipeline by PNP Therapeutics, Inc., H2 2016 219 Head And Neck Cancer - Pipeline by Profectus BioSciences, Inc., H2 2016 220 Head And Neck Cancer - Pipeline by ProNAi Therapeutics, Inc., H2 2016 221 Head And Neck Cancer - Pipeline by Provectus Biopharmaceuticals, Inc., H2 2016 222 Head And Neck Cancer - Pipeline by R-Pharm, H2 2016 223 Head And Neck Cancer - Pipeline by Redx Pharma Plc, H2 2016 224 Head And Neck Cancer - Pipeline by Reliance Life Sciences Pvt. Ltd., H2 2016 225 Head And Neck Cancer - Pipeline by Sanofi, H2 2016 226 Head And Neck Cancer - Pipeline by Sapvax, H2 2016 227 Head And Neck Cancer - Pipeline by Sareum Holdings Plc, H2 2016 228 Head And Neck Cancer - Pipeline by Selecta Biosciences, Inc., H2 2016 229 Head And Neck Cancer - Pipeline by Shanghai Henlius Biotech Co., Ltd., H2 2016 230 Head And Neck Cancer - Pipeline by Shenzen SiBiono GeneTech Co., Ltd., H2 2016 231 Head And Neck Cancer - Pipeline by Shionogi & Co., Ltd., H2 2016 232 Head And Neck Cancer - Pipeline by Silence Therapeutics Plc, H2 2016 233 Head And Neck Cancer - Pipeline by Sillajen Biotherapeutics, H2 2016 234 Head And Neck Cancer - Pipeline by Sinil Pharmaceutical Co., Ltd, H2 2016 235 Head And Neck Cancer - Pipeline by SuviCa Inc., H2 2016 236 Head And Neck Cancer - Pipeline by Symphogen A/S, H2 2016 237 Head And Neck Cancer - Pipeline by SynCore Biotechnology Co., Ltd., H2 2016 238 Head And Neck Cancer - Pipeline by Taiwan Liposome Company, Ltd., H2 2016 239 Head And Neck Cancer - Pipeline by Takara Bio Inc., H2 2016 240 Head And Neck Cancer - Pipeline by Takis S.r.l., H2 2016 241 Head And Neck Cancer - Pipeline by Tara Immuno-Oncology Therapeutics LLC, H2 2016 242 Head And Neck Cancer - Pipeline by Tessa Therapeutics Pte Ltd, H2 2016 243 Head And Neck Cancer - Pipeline by Theravectys SA, H2 2016 244 Head And Neck Cancer - Pipeline by Tolero Pharmaceuticals, Inc., H2 2016 245 Head And Neck Cancer - Pipeline by TyrNovo Ltd., H2 2016 246 Head And Neck Cancer - Pipeline by UbiVac, LLC, H2 2016 247 Head And Neck Cancer - Pipeline by Vaccibody AS, H2 2016 248 Head And Neck Cancer - Pipeline by VasGene Therapeutics, Inc., H2 2016 249 Head And Neck Cancer - Pipeline by Vault Pharma Inc., H2 2016 250 Head And Neck Cancer - Pipeline by Vaxeal Holding SA, H2 2016 251 Head And Neck Cancer - Pipeline by VentiRx Pharmaceuticals, Inc., H2 2016 252 Head And Neck Cancer - Pipeline by Virttu Biologics Limited, H2 2016 253 Head And Neck Cancer - Pipeline by VLPbio, H2 2016 254 Head And Neck Cancer - Pipeline by VM Discovery, Inc., H2 2016 255 Head And Neck Cancer - Pipeline by Vyriad Inc, H2 2016 256 Head And Neck Cancer - Pipeline by Yabao Pharmaceutical Group Co., Ltd., H2 2016 257 Assessment by Monotherapy Products, H2 2016 258 Assessment by Combination Products, H2 2016 259 Number of Products by Stage and Target, H2 2016 261 Number of Products by Stage and Mechanism of Action, H2 2016 275 Number of Products by Stage and Route of Administration, H2 2016 290 Number of Products by Stage and Molecule Type, H2 2016 292 Head And Neck Cancer - Dormant Projects, H2 2016 1114 Head And Neck Cancer - Dormant Projects (Contd..1), H2 2016 1115 Head And Neck Cancer - Dormant Projects (Contd..2), H2 2016 1116 Head And Neck Cancer - Dormant Projects (Contd..3), H2 2016 1117 Head And Neck Cancer - Dormant Projects (Contd..4), H2 2016 1118 Head And Neck Cancer - Dormant Projects (Contd..5), H2 2016 1119 Head And Neck Cancer - Dormant Projects (Contd..6), H2 2016 1120 Head And Neck Cancer - Dormant Projects (Contd..7), H2 2016 1121 Head And Neck Cancer - Dormant Projects (Contd..8), H2 2016 1122 Head And Neck Cancer - Dormant Projects (Contd..9), H2 2016 1123 Head And Neck Cancer - Dormant Projects (Contd..10), H2 2016 1124 Head And Neck Cancer - Dormant Projects (Contd..11), H2 2016 1125 Head And Neck Cancer - Dormant Projects (Contd..12), H2 2016 1126 Head And Neck Cancer - Dormant Projects (Contd..13), H2 2016 1127 Head And Neck Cancer - Dormant Projects (Contd..14), H2 2016 1128 Head And Neck Cancer - Dormant Projects (Contd..15), H2 2016 1129 Head And Neck Cancer - Discontinued Products, H2 2016 1130 Head And Neck Cancer - Discontinued Products (Contd..1), H2 2016 1131 Head And Neck Cancer - Discontinued Products (Contd..2), H2 2016 1132
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
